Zapping thyroid nodules: a Needle-Free alternative to surgery?

NCT ID NCT07140757

Recruiting now Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tracks 50 people who choose radiofrequency ablation (RFA) for benign thyroid nodules or low-risk papillary thyroid cancer instead of surgery. Researchers will monitor long-term outcomes and quality of life using questionnaires. The goal is to see if RFA is a good alternative for those who cannot or prefer not to have surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiofrequency ablation
What this could lead to: If successful, this could show that radiofrequency ablation is a safe, effective option for managing thyroid nodules and low-risk cancers without surgery.
What could go wrong: This is a small, early-stage study focused on tracking outcomes, not proving the treatment works. Results may not apply to all patients, and long-term risks are still unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN THYROID NODULE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign thyroid gland neoplasm thyroid cancer Thyroid Cancer, Papillary thyroid gland papillary carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOW RISK PAPILLARY THYROID CANCER RADIOFREQUENCY ABLATION

Contacts and locations

Locations

MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.